0001628280-24-013993.txt : 20240401 0001628280-24-013993.hdr.sgml : 20240401 20240401151824 ACCESSION NUMBER: 0001628280-24-013993 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231009 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Brady CENTRAL INDEX KEY: 0002002615 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11504 FILM NUMBER: 24808604 MAIL ADDRESS: STREET 1: C/O CHAMPIONS ONCOLOGY, INC. STREET 2: ONE UNIVERSITY PLAZA STE 307 CITY: HACKENSACK STATE: NJ ZIP: 07601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC. CENTRAL INDEX KEY: 0000771856 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521401755 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 410-369-0365 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC. DATE OF NAME CHANGE: 20070220 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS SPORTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL GROUP INC DATE OF NAME CHANGE: 19860319 4 1 wk-form4_1711999092.xml FORM 4 X0508 4 2023-10-09 0 0000771856 CHAMPIONS ONCOLOGY, INC. CSBR 0002002615 Davis Brady C/O CHAMPIONS ONCOLOGY, INC. ONE UNIVERSITY PLAZA, SUITE 307 HACKENSACK NJ 07601 0 1 0 0 President 0 Option to purchase Common Stock 6.50 2023-10-09 4 A 0 135000 6.50 A 2033-10-09 Common Stock 135000 135000 D Option to purchase Common Stock 6.50 2023-10-09 4 A 0 7500 6.50 A 2033-10-09 Common Stock 7500 142500 D Option to purchase Common Stock 6.50 2023-10-09 4 A 0 68000 6.50 A 2033-10-09 Common Stock 68000 210500 D The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively. The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024. The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period. /s/ Brady Davis 2024-04-01